stockportfolio.pro
Charles River Laboratories International, Inc. P/E Ratio 2008–2025
Charles River Laboratories International, Inc. (CRL) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +25.5%/yr over 17 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | — | — |
| FY 2024 | 923.00 | +3499.9% |
| FY 2023 | 25.64 | +11.5% |
| FY 2022 | 22.99 | -53.6% |
| FY 2021 | 49.58 | +42.9% |
| FY 2020 | 34.70 | +15.2% |
| FY 2019 | 30.13 | +23.0% |
| FY 2018 | 24.50 | -43.1% |
| FY 2017 | 43.09 | +82.7% |
| FY 2016 | 23.59 | -8.2% |
| FY 2015 | 25.68 | +7.4% |
| FY 2014 | 23.92 | -4.4% |
| FY 2013 | 25.02 | +34.2% |
| FY 2012 | 18.64 | +46.0% |
| FY 2011 | 12.77 | — |
| FY 2010 | — | — |
| FY 2009 | 19.36 | — |
| FY 2008 | — | — |
Source: Charles River Laboratories International, Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Charles River Laboratories International, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories International, Inc. — frequently asked questions
What is Charles River Laboratories International, Inc.'s price-to-earnings ratio?
Charles River Laboratories International, Inc. (CRL) reported price-to-earnings ratio of 923.00 for fiscal year 2024, per its SEC filings.
How has Charles River Laboratories International, Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2008 and 2025, CRL's price-to-earnings ratio grew at roughly 25.5% per year (compound annual rate), from 19.36 to 923.00.
Where does this data come from?
Figures are computed from Charles River Laboratories International, Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.